Topotecan and Hexalen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Topotecan (topotecan hydrochloride) and Hexalen (altretamine). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Topotecan and Hexalen. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Topotecan?

Topotecan has active ingredients of topotecan hydrochloride. eHealthMe is studying from 5,853 Topotecan users. Check the latest studies of Topotecan.

What is Hexalen?

Hexalen has active ingredients of altretamine. eHealthMe is studying from 45 Hexalen users. Check the latest studies of Hexalen.



On Jul, 14, 2026

12 people who take Topotecan and Hexalen together, and have interactions are studied.

Topotecan and Hexalen drug interactions.

What are the common drug interactions of Topotecan and Hexalen, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal distension
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  6. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Haematuria (presence of blood in urine)
  9. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  10. Hydronephrosis (water inside the kidney)

male:

n/a

What are the common drug interactions of Topotecan and Hexalen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Death
  2. Diarrhoea
  3. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  4. Dyspnoea (difficult or laboured respiration)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fall
  7. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  8. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)

20-29:

n/a

30-39:

n/a

40-49:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Death
  3. Depression
  4. Disease progression
  5. Dizziness
  6. Erythema (redness of the skin)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Loss of consciousness
  10. Metastases to lymph nodes (cancer spreads to lymph node)

50-59:

  1. Abdominal distension
  2. Acquired oesophageal web (structural abnormalities in the oesophagus)
  3. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Haematuria (presence of blood in urine)
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Hydronephrosis (water inside the kidney)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Injury
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

60+:

n/a

What are the existing conditions these people have? *

  1. Ovarian Cancer (cancer of ovary): 11 people, 91.67%
  2. Nausea (feeling of having an urge to vomit): 10 people, 83.33%
  3. Muscle Aches (muscle pain): 10 people, 83.33%
  4. Insomnia (sleeplessness): 10 people, 83.33%
  5. Herpes Virus Infection: 10 people, 83.33%
  6. Osteoporosis (bones weak and more likely to break): 6 people, 50.00%
  7. Breast Cancer: 4 people, 33.33%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Topotecan and Hexalen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Topotecan and Hexalen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Topotecan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hexalen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topotecan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hexalen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on topotecan hydrochloride and altretamine (the active ingredients of Topotecan and Hexalen, respectively), and Topotecan and Hexalen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: